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1. Introduction 
Glaucoma is an optic neuropathy in which the optic nerve is damaged with typical loss of 
nerve fibers and increasing cupping of the optic disc, leading to progressive, irreversible loss 
of vision. Worldwide, glaucoma is the second leading cause of blindness and affects 
aproximatelly 66 million people in the world. There are many different sub-types of glaucoma 
but they can all be considered a type of optic neuropathy.  
The major risk factor for most glaucomas and focus of treatment is increased intraocular 
pressure. Intraocular pressure is a function of production of liquid aqueous humor by the 
ciliary processes of the eye and its drainage through the trabecular meshwork and/or the 
Schlemm´s canal. 
If the condition is detected early enough it is possible to arrest the development or slow the 
progression by medical and surgical means. There is some evidence that prmary surgical 
treatment is superior to primary medical treatment in pateints with open-angle glaucoma.  
First successful antiglaucomatous surgery was performed by german ophthalmologist 
Albrecht von Graefe in 1852. Since early 1970s trabeculectomy described by Sugar, Cairns 
and later Fronimopoulos became the standard of care in open-angle glaucoma surgery. This 
widely used procedure involves a surgically formed pathway for aqueous humor between the 
anterior chamber and the subconjuntival space to lower intraocular pressure in the treatment 
of glaucoma. The main goal is the formation of a conjunctival filtering bleb. This is a 
relatively unphysiological approach and scleral as well as conjunctival scarring led to 
introduction of  antimetabolites as an adjunctive for filtering bleb-depending glaucoma 
surgeries. Numerous intraoperative and postoperative complications have been cited.  
All this led surgeons to search for a more physiological and bleb independent surgical 
approach in IOP lowering glaucoma surgery. Surgical treatment of the natural aqueous 
outflow system, including Schlemm´s canal, to restore normal function and IOP control 
without penetration of the intraocular space has long been the interest in the study of open-
angle glaucoma as an alternative to penetrating and bleb-depending methods.  
 
Several techniques of nonpenetrating filtering glaucoma surgery based on Krasnov´s 
sinusotomy have been described. Stegmann et al. described a variant of nonpenetrating 
glaucoma surgery and termed it viscocanalostomy to emphasize the importance of injecting 
high-viscosity sodium hyaluronate (Healon GV) into the Schlemm´s canal and the surgically 
created ostia as well as into the sclerectomy site under the superficial scleral flap.  
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Further development of non-penetrating approaches included the use of implants at the 
surgical site in the late 1990s and early 2000s.   
All previous non-penetrating glaucoma surgeries were able to reach two to three clock hours 
of Schlemm´s canal while a procedure treating the entire canal should be theoretically more 
effective. We reported on a technique using the 6x0 polypropylene suture for catheterization 
of the entire Schlemm´s canal and while withdrawning the suture a 10x0 polypropylene suture 
is installed in the canal and finally knotted under tension. This is a very difficult and time 
consuming technique with a relatively high risk of mispassage of the 6x0 polypropylene  
suture into the anterior chamber or suprachoroidal space. Recent advances in technology have 
allowed surgeons to use a flexible microcatheter to access the entire length of Schlemm´s 
canal more atraumatically. This technique is called canaloplasty and seems to be the logical 
evolution to viscocanalostomy.  
 
2.  Objectives 
The objectives of the thesis were as follows: 
 - to perform nonpenetrating glaucoma surgery with two different implants in open-angle 
glaucoma and analyzing postoperative outcomes 
- to develop a new surgical technique for glaucomatous eyes with increased outflow 
resistance due to peripheral anterior synechiae and analyzing postoperative outcomes 
- to perform iTrack-assisted canalolasty and analyzing the postoperative intraocular pressure 
lowering effect 
- to develop a surgical technique and instrumentation for canaloplasty with placing a 360° 
tensioning suture into the Schlemm´s canal 
- to develop an intraoperative non-contact system for visualisation of the anterior chamber 
angle and the Schlemm´s canal during canaloplasty 
- to directly demonstrate the way of aqueous outflow after incisional glaucoma surgery and to 
boost the concept of bleb-independent incisional glaucoma surgery 
 
3. Materials and methods 
All patients had open-angle glaucoma and were treated with deep sclerectomy as intraocular 
pressure lowering approach. The semen analysis and evaluation procedures were performed in 
accordance with the WHO 1999 standards criteria. Written informed consent was obtained 
from all patients.  
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Deep sclerectomy with implants 
To avoid secondary collapse of the scleral lake due to adhesion of the superficial scleral flap 
or contact of descemetic window, a space-maintainer implant is placed in the surgically 
created scleral bed. In deep sclerectomy we have used over the past decade SK-Gel (Corneal, 
France) and T-Flux (Carl Zeiss Surgical GmbH, Germany). 
Initially an interindividual retrospective analysis was carried out to compare the outcome of 
both implants. For the study we analyzed four groups. First group included 13 patients with 
deep sclerectomy and implantation of SK-Gel. Second group included 5 patients with 
combined phacoemulsification, intraocular lens implantation and deep sclerectomy with SK-
Gel. In the third group in 31 patinets deep sclerectomy with implantation of T-Flux was 
performed. And finally the fourth group phacoemulsification, intraocular lens implantation 
and deep sclerectomy with T-Flux was performed in 23 patients.  
A second study with intraindividual comparison of both implants in combined 
phacoemulsification and nonpenetrating glaucoma surgery was performed. From January 
2000 to December 2006, 321 eyes of 189 patients were treated with deep sclerectomy and 
simultaneous phacoemulsification in the Augenzentrum Recklinghausen, Germany. Out of 
this number, a total of 17 patients with 34 eyes were identified who had received the 
absorbable device SK-GEL 3.5 in one eye and the nonabsorbable T-Flux device in the 
contralateral eye. Preoperative and postoperative intraocular pressure and medical therapy 
were evaluated for these studies. 
 
Nonpenetrating glaucoma surgery with goniosynechiolysis ab-interno  
The presence of peripheral anterior synechiae usually prevents sufficient aqueous humor 
outflow, possibly leading to surgical failure.  
We therefore developed a surgical technique for selective treatment of peripheral anterior 
synechiae during nonpenetrating glaucoma surgery and retrospectively reviewed medical 
records of patients who had been subject to nonpenetrating glaucoma surgery at our 
department between January 2000 and December 2006. 20 eyes of 16 patients were identified 
who had been scheduled for a combined surgery with non-penetrating glaucoma surgery, 
namely deep sclerectomy with goniosynechiolysis ab interno, introduction of an adjuvant 
implant phacoemulsification and posterior chamber intraocular lens implantation. In all cases 
the indication for the surgery was primary open angle glaucoma with goniosynechia at the 
superior part of the irido-corneal angle and cataract. In none of the eyes the target pressure 
could be achieved by conservative medical therapy because of insufficient efficacy or drug 
 4 
intolerance. A minimum follow-up of 12 months was necessary to qualify for inclusion to this 
study. Following data were collected and analyzed: age, gender, pre- and postoperative 
intraocular pressure (IOP), pre- and postoperative glaucoma medication, type of glaucoma 
implant and complications during and after the surgery. 
 
 iTrack assisted canaloplasty 
To evaluate the effect of canaloplasty pre- and postoperative intraocular pressure and 
antiglaucomatous medical therapy in 73 consecutive eyes with open-angle glaucoma 
(including primary open-angle glaucoma, pseudoexfoliation syndrome and pigment 
dispersion) were analyzed with a minimum follow-up of 12 months.  
 
Catheterless canaloplasty 
If an iTrack assisted canaloplasty would reduce the intraocular pressure by using a 
commercially available, but very expensive catheter, is it possible to bypass the entire 
Schlemm´s canal with a self made catheter? We have used a 6x0 polypropylane suture with 
self made blunt tip to perform canaloplasty.  
 
Intraoperative optical coherence tomography 
To evaluate the use of an intraoperative online anterior segment optical coherence 
tomography (OCT) imaging system for modern glaucoma surgery we used a specially 
designed microscope mounted anterior segment optical coherence tomography device 
(modified Visante, Carl Zeiss Meditech, Germany). This device uses 1300µm wavelength and 
should be therefore suitable for anterior segment visualization including superficial 
intrascleral structures like Schlemm´s canal. Initial tests with a Visante OCT were performed 
in patients after deep sclerectomy to visualize the scleral lake and intrascleral implants. 
Schlemm´s canal could not be shown in this setting. Then the modified microscope mounted 
technology was used for different ophthalmic surgeries but especially for glaucoma surgery to 
visualize the anterior chamber angle and, if possible, the canal of Schlemm.  
 
Flow test after incisional glaucoma surgery 
 
There is still controversy about the mechanism of aqueous humor outflow / resorption in 
intraocular pressure lowering glaucoma surgery. Many studies have been conducted to prove 
postoperative outflow pathway after glaucoma surgery using high resolution ultrasound or 
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optical coherence tomography. But all these techniques could only interpret indirect 
postoperative findings like bleb formation, suprachoroidal space formation etc. We have used 
trypan blue filling of the anterior chamber prior to intended cataract surgery in eyes after 
incisional glaucoma surgery. Then for about 60 seconds the anterior segment was observed to 
check for appearance of the dye. All cases were recorded and afterwards analyzed. Between 
December 2008 and December 2009 twelve eyes with previous incisional glaucoma surgery 
have been tested in this way.   
 
Development of new surgical device / instrument for canaloplasty procedure 
After intensive experience with different nonpenetrating glaucoma surgery procedures and 
canaloplasty some changes in the used instruments and devices became obvious to the author.  
A company (DORC Internation, The Netherlands), experienced in the development of 
ophthalmic microsurgical devices and instruments, was contacted and asked to help in the 
development of  a new simplified catheter for canaloplasty and for improved instrumentation.  
 
4. Results 
Interindividual comparision of SK-Gel versus T-Flux in nonpepetrating glaucoma 
surgery 
Out of the 72 patients included in this study 65 could be followed after 12 months. In the only 
SK-Gel group 10 patients and in the phaco+SK-Gel group 5 patients could be controlled after 
12 months. In the only T-Flux group 28 patients from initially 31 and in the phaco+T-Flux 
group 22 patients from initially 23 could be controlled at the 12 months visit. All patients not 
included at 12 months were excluded because of a second incisional glaucoma surgery during 
the follow-up period.  
The mean preoperative intraocular pressure was 18.4±5.5mmHg and after 12 months 
13.1±3.8mmHg. At no point a significant difference between the subgroups was recognized.  
Complications were minor and included one eye with postoperative positive Seidel test (SK-
Gel group) and one eye with cataract formation requiring surgery at 6 months after the deep 
sclerectomy with T-Flux. Transient ocular hypotension with intraocular pressure below 
7mmHg were found in 28 eyes (39%). In only one eye a revison with resuturing of the scleral 
flap was necessary.  
 
Intraindividual comparision of SK-Gel versus T-Flux in nonpenetrating glaucoma 
surgery 
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Of the 17 patients eligible for case analysis under the above mentioned criteria, 3 were male 
and 14 female with a mean age of 77.1 +6.8 years (± standard deviation). The overall mean 
follow-up period was 26.5 +16.4 months in the SKGEL group and 27.2 +16.0 months in the 
T-Flux group, with a range from 6 to 48 months in both groups. The mean preoperative IOP 
was 20.6 +7.3 in the SKGEL group and 19.9 +7.2 mm Hg in the T-Flux group and hence 
considered comparable (p >0.05). 
In both groups the surgical intervention led to a clinically relevant result: In the SKGEL 
group the mean preoperative IOP decreased to a mean final IOP of 14.8 +5.3 mm Hg (-5.8 
mm Hg or -28.1%), and in the T-Flux group to 14.7 +3.3 mm Hg (-5.2 mm Hg or -26.1%). 
The difference between both groups is statistically not significant (p >0.05). The mean 
number of antiglaucoma medications before surgery was 2.0 +0.8 substances in both groups, 
with a minimum of one substance and a maximum of 4 substances. With both implants the 
need for antiglaucoma treatment decreased after surgery to 0.3 +0.7 medications at the final 
visit. In other terms, only 3 eyes per group required a permanent treatment after surgery, with 
a maximum of 2 substances. 2 eyes, one in each group, needed a transitory therapy with 
betablocker drops for a short time, and no further therapy was necessary in these eyes 
afterwards. 
At the end of the observation period a qualified success (IOP < 21 mm Hg with or without 
treatment) was found in all 17 eyes with the T-Flux device (100%), and in 16 eyes with a 
SKGEL implant (94.1%). Complete success (IOP < 21 mm Hg without treatment) was 
achieved in 14 T-Flux eyes (82.4%) and in 13 SKGEL eyes (76.5%).  
 
Deep sclerectomy with goniosynechioysis ab interno 
With the presented surgical technique, a selective treatment of peripheral anterior synechiae 
was possible during nonpenetrating glaucoma surgery by direct visual control through a 
trabeculo-Descemet’s window in 19 of 20 eyes (95%).  
The mean preoperative IOP was 20.3 ±5.2 mmHg on 2.4 ±1.0 medication. One year 
postoperatively the mean IOP was 15.3 ±3.3 mmHg on 0.6 ±1.0 medication (compared to 
preoperative IOP: p=0.004). 
A postoperative IOP of ≤21mmHg was achieved in 17/19 eyes (89.5%) 3 months, and in 
12/19 eyes (63.2%) 12 months postoperatively without medication. In the remaining 10.5% 
(month 3) and 36.8% (month 12) an addition of a mean of 0.3 and 0.6 medication respectively 
achieved an IOP ≤21mmHg or the target pressure. 
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 iTrack assited Canaloplasty 
Out of more the 200 successfully performed iTrack assisted canaloplasties since March 2008 
seventythree eyes were eligible for case analysis under the above mentioned criteria. The 
mean preoperative intraocular pressure was 23.8±5.6 mmHg. At the 12 months visit the mean 
intraocular pressure was 13.8±2.4 mmHg. Antiglaucomatous medication preoperative was 
2.2±1.0 drugs and dropped to 0.23±1.0 drugs at 12 months. Additional ND-YAG laser 
goiniopuncture had to be performed in 4 eyes. In 32 eyes postoperative hyphema of more then 
1mm was noted. In the remaining 41 eyes at least some erythrozytes or a minimal hyphema 
was noted. None of the cases required an anterior chamber lavage. In 19 eyes a circumscribed 
peripheral descemetic detachment was noted, sometimes with blood in this cavity. In none of 
these cases this complication caused a reduced best corrected visual acuity in the 
postoperative period. Absorbtion of the OVD and/or blood could take up to several months. 
Two eyes had transient choroidal detachment. Non of these eyes developled a maculopathy. 
Overall no serious complication was noted. No eye required additional glaucoma surgery 
during the first 12 months postoperative period.  
Qualified success rate after 12 months with regards to a postoperative target pressure of 
18mmHg was 90.4%. Complete success rate was 86.3%. 
 
Catheterless Canaloplasty 
Since September 2006 we have performed 156 deep sclerectomies with 6x0 polypropylene 
assisted canaloplasty with successful placing 10x0 tensioning suture. Preparation of a blunt 
tipped slightly curved 6x0 polypropylene suture was possible. After initial success with 
relatively easy passage of the suture, encqouraging us to continue and improve the technique, 
most cases did require several attemps to pass the suture 360°. If the suture could not pass in 
one direction a second attempt was made in the opposite direction. In case of sudden stop, 
indicating a mispassage into a large collector channel or a fibrosed Schlemm´s canal,  the 6x0 
polypropylane suture was left in place and a second 6x0 polypropylene suture was advanced 
into the canal. In same cases additional maneuvers like benting the tip of the suture like with 
iTrack assisted canaloplasty was necessary.  
In 15 eyes a misdirection of the suture with perforation into the anterior chamber or the 
suprachoroidal space was noted. But in all of these eyes finally the 360° cannulation could be 
completed and a 10x0 polypropylene suture placed.  
In another 26 eyes the cannulation of the Schlemm´s canal could not be completed. In these 
cases SK-Gel was implanted in the sclerectomy site. Finally in 3 eyes macro perforation with 
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conversion to penetrating glaucoma surgery with peripheral iridectomy occurred. In these 
eyes no implant could be placed under the superficial scleral flap.  
In two eyes with aphakia and open angle glaucoma secondary to pseudoexfoliation syndrome 
we have used catheterless canaloplasty in combination with implantation of  a posterior 
chamber intraocular lens with intrascleral haptic fixation. This technique we have developed 
for eyes with insufficient or no capsular support.  Because this technique does not require 
anterior chamber angle haptic fixation or iris fixation it is especially usefull in glaucomatous 
eyes. 
 
Intraopertive optical coherence tomography 
With permission of the local ethics committee we have performed optical coherence 
tomography in more then 80 ophthalmic surgeries, including nonpenetrating glaucoma 
surgery. In all cases we have initially looked for Schlemm´s canal. In none of the cases the 
canal was clearly visible preoperatively. In all 8 cases of canaloplasty with intraoperative use 
of optical coherence tomography the Schlemm´s canal was clearly visible during the 
cannulation with iTrack catheter. In these cases we have used the iTack catheter to inject 
ophthalmic viscosurgical device to enlarge the lumen of the Schlemm´s canal. This was 
clearly visible, but in 3 eyes the lumen of the canal did enlarge less dramatically due to 
microperforation of the inner wall of Schlemm´s canal.  
After placing the tensioning suture in all 8 eyes with canaloplasty a distension of the inner 
wall of schlemm´s canal could be observed, indicating successful distension. Distension was 
checked next to the sclerectomy site, at 3, 6 and 9 o´clock position. Distension was in all 
cases highest next to the sclerectomy site, but same at 3, 6 and 9 o´clock position. Distension 
suture within the lumen of the Schlemm´s canal was visible in all cases. 
No device related complication occurred. The device was easy to use with the help of a 
trained assistance.  
 
Flow test after incisional glaucoma surgery 
Five eyes after previous trabeculectomy have been operated. While two eyes showed a typical 
pattern of cystic conjunctival bleb, two eyes showed no sign of external filtration and only 
one eye did show a formation of a subconjunctival bleb with diffuse subconjunctival 
filtration. Five eyes after deep sclerectomy did show a diffuse subconjunctival filtration with 
at least in two eyes signs of mixed resorption with trypan blue filling of episcleral veins.  
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Two eyes after successful canaloplasty showed no sign of subconjunctival filtration but filling 
of episcleral veins with tryptan blue.  
In all eyes with external appearance of trypan blue this occurred in the surgical site or next to 
the surgical area. No complication related to this flow test occurred.  
 
Glaucolight and Scharioth´s glaucoma forceps 
After more then 12 months of processing and testing a new catheter for canaloplasty was 
developed and is now commercially available.  
This device is called Glaucolight. It is a specially designed lightfiber with an atraumatic tip 
design for smooth transfer through the Schlemm´s canal. Its outer diameter is only 150µm. 
This small diameter allows flexible 360° followability of the Schlemm´s canal. The material 
is ductile. Bending the tip reduces the risk for misdirection of the catheter during the passage 
through Schlemm´s canal. It has an integrated battery powered red LED light source. The 
LED is switched on simply by pressing a contact on the case. The battery lasts for several 
hours. The illuminated tip indicates the position of the catheter in the Schlemm´s canal during 
the passage. The special suture fixation notch at the distal end of the fiber assures a firm 
fixation of the stretching-suture in combination with minimizing injury effect of the suture 
knot to the wall of Schlemm´s canal during the withdrawn. The clip attached to the light 
source is used to fix the catheter to the sterile patients drape next to surgical area during the 
procedure. 
During the testing period 22 eyes have been operated with this new device and in all cases a 
successful 360° cannulation could be performed. No complication related to the device 
occurred. The passage through the Schlemm´s canal was found smooth and atraumatic.  
The forceps developed for modern glaucoma procedures is a modified tying forceps with an 
enlarged tip with a groove for easier and safer grasping of the catheter during cannulation. 
This atraumatic tip could also be used during the procedure for atraumatic but safe 
manipulation of the scleral flap.  
The distal end of the forceps has a special marker for blunt marking of a parabolic 5x5mm 
superficial scleral flap. The special design of this marker allows observation of the episcleral 
vessels during marking to select an adaequate area for dissection. This reduces the need for 
diathermy during flap preparation.  
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5. Summary and conclusions 
The results of our retrospective analysis confirm the results of other studies, in that in open-
angle glaucoma a deep sclerectomy with implantation of a device in combination with 
phacoemulsification lowers IOP in a clinically relevant way over a long period. 
We proved that the effect of deep sclerectomy with implantation of a device is independent 
from the absorbable or nonabsorbable property of the implant, while the risks of a combined 
surgery are few when performed by an experienced surgeon. 
 
Peripheral anterior synechiae could cause failure in nonpenetrating glaucoma surgery. We 
developed a new technique for release of goniosynechiae in the area of the descemetic 
window and could prove that with this new surgical technique deep sclerectomy could be 
performed successfully in case of peripheral anterior synechiae without the need of 
conversion to penetrating glaucoma surgery. 
 
Canaloplasty is a new effective bleb-independent intraocular pressure lowering-procedure 
with a very low complication rate.  
As an unreported postoperative finding almost all eyes had some amount of intracameral 
bleeding. 
 
The commercially available catheters for canaloplasty (Glaucolight, DORC, The Netherlands 
and iTrack, iScience, USA)  reduces surgical time and improves the safety of the procedure. 
But canaloplasty can be performed even without the need of this expensive device with the 
help of a self made catheter (blunt tipped polypropylene suture 6x0). As a new finding we 
could show that the procedure was successful even without injection of ophthalmic 
viscosurgical device throughout the entire Schlemm´s canal.  
Our new catheter and forceps simplifies intraoperative manipulations.  
Longer follow-up is needed to understand the long term success rate and effects of the 
tensioning suture on intraocular tissue. 
 
Intraoperative optical coherence tomography is a new technique to visualize intraocular 
structures with very high resolution. This technology could be helpful in modern glaucoma 
surgery as well as other ophthalmic surgical techniques (i.e. refractive intraocular implants, 
corneal surgery, femtosecond-assisted cataract surgery). We could show that this new system 
is able to image intraoperative the Schlemm´s canal and distension of the inner wall of 
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Schlemm´s canal during canaloplasty. Further development of this system with higher 
resolution and improved recording speed is recommended. Faster computer technology could 
lead to three dimensional imaging with new options in ophthalmic surgery and diagnostics. 
 
To prove the concept of bleb-independent glaucoma surgery we have developed  the 
intraoperative flow test with trypan blue. With this test the outflow of aqueous humor after 
incisional glaucoma surgery was directly visualized. At least in some eyes we could prove the 
bleb independent character of canaloplasty.  
 
Nonpenetrating bleb independent glaucoma surgery is possible, has a very low complication 
rate  and could lead to re-establishing the natural outflow in patients with open-angle 
glaucoma.  
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